PillRx only · Tablet · Oral
Tolvaptan
Brands: Jynarque · Samsca · Tolvaptan
8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US19 NDCs
8 active makers
8 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$16.756
Latest avg · Jul 22, 2026
-37%
Since Dec 17, 2025
8
Active US suppliers
53%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
238
Rx · 2026 Q1
6.8K
Units dispensed
+25%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it8 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Ascend Laboratories, LLC | unknown | 9 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 8 | SUPPLYING |
| Otsuka America Pharmaceutical, Inc. | unknown | 4 | SUPPLYING |
| Apotex Corp. | unknown | 3 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 2 | SUPPLYING |
| NorthStar Rx LLC | unknown | 2 | SUPPLYING |
| Endo USA, Inc. | unknown | 2 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.